Evonetix is a Cambridge, UK-based synthetic biology company. The main goals of the company are to engineer metabolic pathways and organisms, improve industrial processes, and create new processes. Evonetix also engineers genomes with new and improved traits and use DNA as a medium for digital data storage.
Timeline
March 2, 2020
Evonetix raises a $30,000,000 series B round from Foresite Capital.
July 2, 2018
Evonetix raises a $1,805,375 grant from Innovate UK.
January 30, 2018
Evonetix raises a $12,300,000 series A round from Cambridge Consultants, Civilization Ventures, DCVC Bio, Draper Esprit, Providence Investment Company Limited and Rising Tide.
2015
Evonetix was founded by Joseph Brennan and Matthew Hayes.
Funding rounds
People
Name
Role
LinkedIn
Further reading
Title
Author
Link
Type
Date
Documentaries, videos and podcasts
Title
Date
Link
Companies
Company
CEO
Location
Products/Services
Is a
Company attributes
Location
Company status
Active
B2X
CEO
Founder
Crunchbase
Pitchbook
Legal name
Evonetix Ltd
Date incorporated
2015
Spun out from
Number of Employees (ranges)
20 – 49
Full address
C P C 1 Capital Park, Fulbourn CAMBRIDGE , CB21 5XE United Kingdom
Investors
Total funding amount (USD)
44,105,375
Latest funding round date
March 2, 2020
Latest funding type
Other attributes
Country
Categories
Related Topics
Contributors
- 1
Carla Faraguna
Golden People and Operations. - 2
Bridget Smith
I am a Copywriter and Researcher. - 3
Erin Scherfner
loading information... - 4
Chirag Jain
I am an engineer and a traveler. I love to explore new things around the world and I am on the way of it. I love to take challenges. Thanks! - 5
Gautam Abhishek
Influencer, Software Engineer, internet surfing & Technology Lover - 6
Amy Sar
Data entry, interested in artificial Intelligence and NLP. - 7
Neelam Jhaveri
Techno Geek + Gamer + Fashionista + Sense of Humor = It's ME - 8
Bhupendra Solanki
Researcher - 9
Jude Gomila
Founder and CEO of Golden, Entrepreneur. Investor in 200+ companies. Cantabrigian (Gonville and Caius). Interested in the Universe. - 10
Rachel Phythian
Advisor / Investor
